US Patent 7232797 Erythropoietin dosing regimen for treating anemia

Patent 7232797 was granted and assigned to Ortho-McNeil Pharmaceutical on June, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Ortho-McNeil Pharmaceutical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7232797

Date of Patent

June 19, 2007

Patent Application Number

10304382

Date Filed

November 26, 2002

Patent Primary Examiner

Nashaat T. Nashed

Patent abstract

The present invention provides a new subcutaneous injection dosing regimen for erythropoietin to treat anemia. The new erythropoietin treatment regimen of the present invention results in improved hemoglobin levels with less frequent dosing.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7232797 Erythropoietin dosing regimen for treating anemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API